Integrated Review Debate

Full Debate: Read Full Debate
Department: Leader of the House

Integrated Review

Baroness Northover Excerpts
Wednesday 17th March 2021

(3 years, 1 month ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Baroness Evans of Bowes Park Portrait Baroness Evans of Bowes Park (Con)
- Hansard - - - Excerpts

As I said, the review makes quite clear that we are committed to spending 0.7% of GNI on ODA as soon as the economic situation allows, and we believe that we are acting compatibly with the International Development Act. We believe that this review will once again put us at the forefront of global leadership in a whole array of areas. We will look forward to working with partners in Europe, around the globe and, obviously, in the Indo-Pacific region, which we have also pointed out, in order to advance open and fair democracies and societies.

Baroness Northover Portrait Baroness Northover (LD) [V]
- Hansard - -

My Lords, the review puts science and technology front and centre. How does the noble Baroness square that with Universities UK stating today that the Government have failed to provide more than £1 billion for its membership of the Horizon programme? The UK’s national research funding agency—UKRI—is being forced to make cuts of £125 million because of ODA cuts. Is she aware that it was ODA money that helped to fund the Oxford Jenner Institute vaccine work?

Baroness Evans of Bowes Park Portrait Baroness Evans of Bowes Park (Con)
- Hansard - - - Excerpts

We certainly have an incredibly strong record on science and technology. We are ranked fourth in the Global Innovation Index, and we will invest £14.6 billion in R&D across government in 2021-22. We have reached agreement to take part in Horizon Europe, which is an excellent outcome. We are currently working through the details of the costs and where they fall, but we have always been clear that Horizon funding complements domestic programmes and have made a public commitment that there will be no loss of investment in R&D in the UK on leaving the EU.